siRNA, Anti-Human ALAS2, LNA(CAT#: SIRGT04139WQ-LNA)

The product SIRGT04139WQ-LNA is a type of small interfering RNA (siRNA) that targets ALAS2 gene and regulates the expression of gene. The siRNA interferes with the expression of ALAS2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000032.4; NM_001037967.3; NM_001037968.3
Alternative Names ALAS-E; ALASE; ANH1; ASB; SIDBA1; XLDPP; XLEPP; XLSA
Related Diseases Anemia, Protoporphyria
Purification HPLC
Target Gene
Gene ID 212
Uniprot ID P22557

Related Products